Raj et al. (2021) found that FXS cortical organoids at differentiation day 28 exhibited a higher percentage of Ki67+SOX2+ proliferative cells compared to the controls, supporting their findings in 2D cellular models that loss of FMRP led to abnormal proliferation and cell cycle alterations in FXS [21]. The gene discussed is SOX2; the disease is fragile X syndrome.